Free Trial

UiPath (NYSE:PATH) Stock Price Up 8% - Here's What Happened

UiPath logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Shares jumped about 8%, trading as high as $17.33 on Tuesday with ~29.8 million shares changing hands (vs. a ~31.3M average); UiPath has a market cap near $9.25B and its 50-/200‑day moving averages are $15.56 and $13.69, respectively.
  • Positive catalysts include thematic coverage from Zacks naming PATH among top robotics/small‑ and mid‑cap AI picks and a recent earnings beat (Qtr EPS $0.16 vs. $0.14; revenue $411.1M vs. $392.5M), but analysts’ consensus is still a "Hold" with an average target of $15.85.
  • Notable insider selling occurred on Jan. 5 (CFO sold 67,468 shares; CEO sold 45,000), and insiders have sold ~1.89M shares in the past 90 days, which may weigh on sentiment despite significant institutional ownership (≈62.5%).
  • Interested in UiPath? Here are five stocks we like better.

UiPath, Inc. (NYSE:PATH - Get Free Report)'s share price traded up 8% during trading on Tuesday . The stock traded as high as $17.33 and last traded at $17.3050. 29,830,576 shares changed hands during mid-day trading, a decline of 5% from the average session volume of 31,314,791 shares. The stock had previously closed at $16.03.

Key UiPath News

Here are the key news stories impacting UiPath this week:

  • Positive Sentiment: Industry/stock picks: PATH was named among Zacks’ top robotics stocks and included on a Zacks list of small- and mid-cap AI names that could outperform in 2026 — positive thematic coverage that can boost investor interest in PATH as an AI/automation play. Top Robotics Stocks That Could Drive Impressive Returns in 2026
  • Positive Sentiment: Additional bullish coverage from Zacks highlighting PATH among small/mid AI names could attract momentum flows and retail/institutional interest into the stock. Buy These 5 Small and Mid-Sized AI Stocks for Stellar Returns in 2026
  • Positive Sentiment: Institutional backing: MarketBeat notes large institutional stakes and recent increases by major holders (Vanguard, TFG, AQR, etc.), which supports liquidity and provides a baseline of demand under the shares. UiPath Stock Page
  • Neutral Sentiment: Investor event: UiPath announced CFO/COO Ashim Gupta will speak at the Needham Growth Conference on Jan. 13 — a standard investor forum that gives management a chance to reinforce guidance/strategy but is neutral until new disclosures are made. UiPath to Participate in the 28th Annual Needham Growth Conference
  • Neutral Sentiment: Product/tech relevance: Coverage (Diginomica) highlights UiPath’s agentic AI capabilities in regulated industries — this underscores product strength but is qualitative and may take time to affect revenue. Evergen and UiPath show how agentic AI tests process discipline in regulated industries
  • Negative Sentiment: Insider selling: CFO Ashim Gupta sold 67,468 shares on Jan. 5 (disclosed filing) and CEO Daniel Dines sold 45,000 shares the same day — continued insider sales (Dines has been selling repeatedly) are a negative signal to some investors even if total ownership remains large. SEC Filing - Gupta Sale SEC Filing - Dines Sale
  • Negative Sentiment: Analyst action: RBC cut its price target to $17 from $19 on Jan. 5 — a downward target revision can weigh on sentiment and limit near-term upside expectations. UiPath price target lowered to $17 from $19 at RBC Capital

Wall Street Analysts Forecast Growth

PATH has been the subject of several research analyst reports. Evercore ISI increased their price objective on UiPath from $15.00 to $17.00 and gave the stock an "in-line" rating in a research note on Thursday, December 4th. UBS Group reissued a "neutral" rating on shares of UiPath in a research report on Thursday, December 4th. Mizuho raised their price target on shares of UiPath from $14.00 to $15.00 and gave the stock a "neutral" rating in a report on Thursday, December 4th. Morgan Stanley upped their price objective on shares of UiPath from $15.00 to $19.00 and gave the company an "equal weight" rating in a research note on Tuesday, December 9th. Finally, Barclays increased their target price on shares of UiPath from $14.00 to $16.00 and gave the stock an "equal weight" rating in a research report on Thursday, December 4th. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, fourteen have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $15.85.

Read Our Latest Stock Report on UiPath

UiPath Price Performance

The stock has a market capitalization of $9.25 billion, a price-to-earnings ratio of 41.20, a PEG ratio of 4.80 and a beta of 1.08. The stock's 50 day simple moving average is $15.56 and its 200-day simple moving average is $13.69.

UiPath (NYSE:PATH - Get Free Report) last announced its quarterly earnings results on Wednesday, December 3rd. The company reported $0.16 EPS for the quarter, topping the consensus estimate of $0.14 by $0.02. The company had revenue of $411.11 million for the quarter, compared to analyst estimates of $392.46 million. UiPath had a net margin of 14.79% and a return on equity of 3.73%. UiPath's quarterly revenue was up 15.9% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.11 EPS. As a group, equities research analysts anticipate that UiPath, Inc. will post -0.17 earnings per share for the current fiscal year.

Insider Transactions at UiPath

In related news, CFO Ashim Gupta sold 67,468 shares of the business's stock in a transaction that occurred on Monday, January 5th. The stock was sold at an average price of $16.10, for a total value of $1,086,234.80. Following the completion of the sale, the chief financial officer directly owned 557,028 shares in the company, valued at approximately $8,968,150.80. The trade was a 10.80% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Daniel Dines sold 45,000 shares of the company's stock in a transaction that occurred on Monday, January 5th. The stock was sold at an average price of $15.73, for a total value of $707,850.00. Following the sale, the chief executive officer directly owned 28,343,585 shares of the company's stock, valued at $445,844,592.05. The trade was a 0.16% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 1,889,438 shares of company stock valued at $31,534,515 in the last ninety days. Insiders own 23.19% of the company's stock.

Institutional Trading of UiPath

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Comerica Bank lifted its holdings in shares of UiPath by 134.8% during the first quarter. Comerica Bank now owns 27,924 shares of the company's stock worth $288,000 after buying an additional 16,030 shares during the last quarter. Royal Bank of Canada increased its position in UiPath by 8.4% during the first quarter. Royal Bank of Canada now owns 140,774 shares of the company's stock worth $1,450,000 after acquiring an additional 10,872 shares during the period. Focus Partners Advisor Solutions LLC raised its stake in UiPath by 87.9% during the 1st quarter. Focus Partners Advisor Solutions LLC now owns 23,301 shares of the company's stock valued at $240,000 after purchasing an additional 10,899 shares during the last quarter. Amundi boosted its holdings in UiPath by 7.6% in the 1st quarter. Amundi now owns 672,171 shares of the company's stock valued at $6,896,000 after purchasing an additional 47,313 shares during the period. Finally, Advisors Asset Management Inc. boosted its holdings in UiPath by 570.3% in the 1st quarter. Advisors Asset Management Inc. now owns 69,406 shares of the company's stock valued at $715,000 after purchasing an additional 59,052 shares during the period. Institutional investors and hedge funds own 62.50% of the company's stock.

UiPath Company Profile

(Get Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in UiPath Right Now?

Before you consider UiPath, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.

While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines